11-60383163-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021201.5(MS4A7):āc.22A>Cā(p.Met8Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_021201.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MS4A7 | NM_021201.5 | c.22A>C | p.Met8Leu | missense_variant | Exon 2 of 7 | ENST00000300184.8 | NP_067024.1 | |
MS4A7 | NM_206939.2 | c.22A>C | p.Met8Leu | missense_variant | Exon 2 of 7 | NP_996822.1 | ||
MS4A7 | NM_206938.2 | c.22A>C | p.Met8Leu | missense_variant | Exon 2 of 6 | NP_996821.1 | ||
MS4A7 | NM_206940.2 | c.22A>C | p.Met8Leu | missense_variant | Exon 2 of 6 | NP_996823.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251268Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135792
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461710Hom.: 0 Cov.: 30 AF XY: 0.0000206 AC XY: 15AN XY: 727146
GnomAD4 genome AF: 0.000125 AC: 19AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.22A>C (p.M8L) alteration is located in exon 2 (coding exon 1) of the MS4A7 gene. This alteration results from a A to C substitution at nucleotide position 22, causing the methionine (M) at amino acid position 8 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at